These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10863308)

  • 41. [AIDS. Therapeutic approaches in the control of HIV infection].
    Müller WE; Schröder HC
    Med Monatsschr Pharm; 1990 May; 13(5):141-6. PubMed ID: 2192245
    [No Abstract]   [Full Text] [Related]  

  • 42. [HIV: "big bang" in view].
    Vernazza PL
    Schweiz Med Wochenschr; 1997 Dec; 127(51-52):2129-31. PubMed ID: 9487573
    [No Abstract]   [Full Text] [Related]  

  • 43. Elite controllers as a model of functional cure.
    Autran B; Descours B; Avettand-Fenoel V; Rouzioux C
    Curr Opin HIV AIDS; 2011 May; 6(3):181-7. PubMed ID: 21460722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antimicrobial peptides: a potential arsenal against HIV infection].
    Castañeda-Delgado JE; Cervantes-Villagrana AR; Rivas-Santiago B
    Invest Clin; 2012 Mar; 53(1):71-83. PubMed ID: 22524110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydroxyurea and HIV: 5 years later--from antiviral to immune-modulating effects.
    Lori F
    AIDS; 1999 Aug; 13(12):1433-42. PubMed ID: 10465065
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapeutic interventions in primary HIV infection.
    Kinloch-de Loës S; Perrin L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S69-76. PubMed ID: 8595514
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinicians' discussion: trends in HIV care.
    Braun J; el-Sadr W; Merrick S; Rubin D; Vogler M; Frost KR
    AIDS Read; 2000 Apr; 10(4):233-40. PubMed ID: 10808606
    [No Abstract]   [Full Text] [Related]  

  • 48. HIV/AIDS research. Tissue says blood is misleading, confusing HIV cure efforts.
    Cohen J
    Science; 2011 Dec; 334(6063):1614. PubMed ID: 22194536
    [No Abstract]   [Full Text] [Related]  

  • 49. Safety of hydroxyurea in the treatment of HIV infection.
    Lori F; Kelly LM; Foli A; Lisziewicz J
    Expert Opin Drug Saf; 2004 Jul; 3(4):279-88. PubMed ID: 15268646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [HIV infection. Immunopathology and pathogenesis].
    Schaad UB
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):388-90. PubMed ID: 1922116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV virology and pathogenetic mechanisms of infection: a brief overview.
    Fanales-Belasio E; Raimondo M; Suligoi B; Buttò S
    Ann Ist Super Sanita; 2010; 46(1):5-14. PubMed ID: 20348614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stages of HIV replication and targets for therapeutic intervention.
    Tözsér J
    Curr Top Med Chem; 2003; 3(13):1447-57. PubMed ID: 14529520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapeutic drugs--rarely causal therapy].
    Uhl D
    Med Monatsschr Pharm; 1990 May; 13(5):129. PubMed ID: 2192241
    [No Abstract]   [Full Text] [Related]  

  • 54. [Vaccines, molecular scissors, fusion inhibitors. What does HIV therapy of the future look like?].
    Warpakowski A
    MMW Fortschr Med; 2009 Nov; 151(46):22-3. PubMed ID: 20043388
    [No Abstract]   [Full Text] [Related]  

  • 55. Can immune systems be trained to fight HIV?
    Balter M
    Science; 1999 Nov; 286(5444):1470-11. PubMed ID: 10610544
    [No Abstract]   [Full Text] [Related]  

  • 56. HIV immunopathogenesis and strategies for intervention.
    Cadogan M; Dalgleish AG
    Lancet Infect Dis; 2008 Nov; 8(11):675-84. PubMed ID: 18818125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Strategies for the use of anti-retroviral agents in HIV infection (1997). Extracts from the 4th Dormont Report].
    Rev Pneumol Clin; 1998 Feb; 54(1):9-16. PubMed ID: 9769979
    [No Abstract]   [Full Text] [Related]  

  • 58. Exploring how to get at--and eradicate--hidden HIV.
    Cohen J
    Science; 1998 Mar; 279(5358):1854-5. PubMed ID: 9537902
    [No Abstract]   [Full Text] [Related]  

  • 59. Trends. Aging HIV population faces unique health challenges, officials say.
    AIDS Policy Law; 2010 Oct; 25(11):1, 4. PubMed ID: 21053399
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current trials of HIV management].
    Yazaki H; Oka S
    Nihon Rinsho; 2007 Mar; 65 Suppl 3():247-50. PubMed ID: 17494152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.